Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Fibion is a sedentary behavior and daily activity analysis service from Finland, combining hardware-based measurement with SaaS reporting. It mails dedicated measurement devices to users to collect activity data over 3–7 days for individuals, or 1 day per person for group members. The service then generates scientifically validated analytical reports and personalized recommendations, aiming to help individuals improve daily activity habits while helping companies assess workplace health risks and optimize ergonomics.
The official website does not publish a specific pricing table and instead uses a quote-based model. Its business model leans toward B2B2C, allowing health service providers or companies to purchase in bulk. The site mentions that service providers can receive a 30% discount. It also offers a free 15-minute Skype consultation to encourage conversion.
Pros: Scientifically validated, with highly credible data; supports both in-depth individual analysis and broad organizational analysis; reports go beyond data visualization by offering actionable automated recommendations and goal simulations; especially suited to office environments, with the ability to assess the ROI of investments such as height-adjustable desks.
Cons: Heavily dependent on mailing physical hardware, so it is not a pure software SaaS product; delivery cycles are longer and logistics costs are involved; in group mode, each person is sampled for only 1 day, which may limit data representativeness; lacks publicly available standardized pricing and API integration details.
Primarily aimed at B2B customers: workplace wellness and HR managers, ergonomic furniture suppliers (for example, to assess furniture usage rates), health professionals such as physical therapists and personal trainers, and organizations that need to carry out preventive healthcare interventions.
Unknown. As a localized Finnish service, the website mainly targets Europe. There may be no major network-level restrictions on access from China, but cross-border hardware shipping and localized service support create significant barriers to practical adoption.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on fibion.pro official site.
fibion.pro is an Finland Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach fibion.pro directly.